Bioqual (Bioqual) Additional Paid-In Capital : $7.33 Mil(As of May. 2018)

View and export this data going back to . Start your Free Trial

What is Bioqual Additional Paid-In Capital?

Bioqual's quarterly additional paid-in capital declined from May. 2011 ($7.33 Mil) to May. 2017 ($7.33 Mil) but then increased from May. 2017 ($7.33 Mil) to May. 2018 ($7.33 Mil).

Bioqual's annual additional paid-in capital declined from May. 2011 ($7.33 Mil) to May. 2017 ($7.33 Mil) but then increased from May. 2017 ($7.33 Mil) to May. 2018 ($7.33 Mil).

Bioqual Additional Paid-In Capital Historical Data

The historical data trend for Bioqual's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual Additional Paid-In Capital Chart

Bioqual Annual Data

Trend

May01

May03

May04

May05

May06

May07

May10

May11

May17

May18

Additional Paid-In Capital

Get a 7-Day Free Trial

7.32

7.33

Bioqual Semi-Annual Data
	May96	May97	May98	May99	May00	May01	May03	May04	May05	May06	May07	May10	May11	May17	May18
Additional Paid-In Capital	Get a 7-Day Free Trial										7.32	7.33	7.33	7.33	7.33

Bioqual Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Bioqual Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Bioqual's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioqual (Bioqual) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » Additional Paid-In Capital

Comparable Companies

STIM VNRX PSNL PRE MDXH ENZ TTOO BNR NOTV ACRS TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

N/A

Address

9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850

Website

https://www.bioqual.com

Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.

Executives

Williams Frank E Jr

other: Communication, See Remarks

2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines